NDC 0061-1088 - Optimmune Ophthalmic
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0061-1088
- Package NDCs from labels
- 0061-1088-01
- Manufacturer
- Merck Sharp & Dohme Corp.
- Effective date
- 2026-01-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Optimmune ® (0.2% Cyclosporine, USP) Ophthalmic Ointment | Merck Sharp & Dohme Corp. | 2026-01-16 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0061-1088-01 | Optimmune Ophthalmic | 3.5 g in 1 TUBE | OINTMENT | 3.5 | 10 | |
| 0061-1088-01 | Optimmune Ophthalmic | 1 in 1 CARTON | OINTMENT | 1 | 10 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Cyclosporine | ACTIVE INGREDIENT | 83HN0GTJ6D | OPTIMMUNE (CYCLOSPORINE) OINTMENT [SCHERING CORPORATION] | 2 | |
| Cyclosporine | ACTIVE MOIETY | 83HN0GTJ6D | OPTIMMUNE (CYCLOSPORINE) OINTMENT [SCHERING CORPORATION] | 2 | |
| Corn Oil | INACTIVE INGREDIENT | 8470G57WFM | OPTIMMUNE (CYCLOSPORINE) OINTMENT [SCHERING CORPORATION] | 2 | |
| Lanolin Alcohols | INACTIVE INGREDIENT | 884C3FA9HE | OPTIMMUNE (CYCLOSPORINE) OINTMENT [SCHERING CORPORATION] | 2 | |
| Paraffin | INACTIVE INGREDIENT | I9O0E3H2ZE | OPTIMMUNE (CYCLOSPORINE) OINTMENT [SCHERING CORPORATION] | 2 | |
| Petrolatum | INACTIVE INGREDIENT | 4T6H12BN9U | OPTIMMUNE (CYCLOSPORINE) OINTMENT [SCHERING CORPORATION] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CycloSPORINE, Modfied | CYCLOSPORINE | Apotex Corp. | 5baaf78c-90f6-abcf-52c8-814490f3cf9f | 2026-09-10 | Boxed warning, Warnings, Adverse reactions | 83HN0GTJ6D |
| Cyclosporine | CYCLOSPORINE | Strides Pharma Science Limited | c36132b2-3ec7-4c43-a25e-75cbdbe3d88d | 2026-08-27 | Boxed warning, Warnings, Adverse reactions | 83HN0GTJ6D |
| Neoral | CYCLOSPORINE | Novartis Pharmaceuticals Corporation | 94461af3-11f1-4670-95d4-2965b9538ae3 | 2026-08-10 | Boxed warning, Warnings, Adverse reactions | 83HN0GTJ6D |
| Sandimmune | CYCLOSPORINE | Novartis Pharmaceuticals Corporation | 5e5926a7-1de0-4b54-a5c0-286b6200ff82 | 2026-07-10 | Boxed warning, Warnings, Adverse reactions | 83HN0GTJ6D |
| CEQUA | CYCLOSPORINE | Sun Pharmaceutical Industries, Inc. | 48c3d8a3-4289-4b52-9189-58b48596095c | 2026-06-15 | Warnings, Adverse reactions | 83HN0GTJ6D |
| Verkazia | CYCLOSPORINE | Harrow Eye, LLC | 48651d30-9e6e-74b0-e063-6294a90a8337 | 2026-06-03 | Warnings, Adverse reactions | 83HN0GTJ6D |
| CYCLOSPORINE | CYCLOSPORINE | Upsher-Smith Laboratories, LLC | f7e4a2f0-ea2a-449b-bc6d-a6ea3d47b850 | 2026-05-22 | Warnings, Adverse reactions | 83HN0GTJ6D |
| Cyclosporine | CYCLOSPORINE | Apotex Corp. | bfca7088-fe93-abb9-3ec3-e6f5710a69c6 | 2026-04-22 | Boxed warning, Warnings, Adverse reactions | 83HN0GTJ6D |
| VEVYE | CYCLOSPORINE OPHTHALMIC SOLUTION | Harrow Eye, LLC | 0a60fccf-7e1b-44fe-e063-6394a90aadd5 | 2026-02-26 | Warnings, Adverse reactions | 83HN0GTJ6D |
| CYCLOSPORINE | CYCLOSPORINE | Saptalis Pharmaceuticals, LLC | ff4dc2fc-667a-489a-b798-8d11cddfe716 | 2025-12-09 | Warnings, Adverse reactions | 83HN0GTJ6D |
| CYCLOSPORINE | CYCLOSPORINE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | 1952d4c7-a40e-4924-b669-c41400774cb9 | 2025-12-04 | Boxed warning, Warnings, Adverse reactions | 83HN0GTJ6D |
| Restasis MultiDose | CYCLOSPORINE | Allergan, Inc. | 7224d810-bb96-4682-a942-3355e6e8061a | 2025-08-21 | Warnings, Adverse reactions | 83HN0GTJ6D |
| Cyclosporine | CYCLOSPORINE | Devatis Inc. | 7bb2078d-17c2-4e6a-9f61-26c7ecbce945 | 2025-02-17 | Warnings, Adverse reactions | 83HN0GTJ6D |
| Verkazia | CYCLOSPORINE | Santen Incorporated | c795cd2f-89da-78e3-e053-2a95a90a9422 | 2025-01-17 | Warnings, Adverse reactions | 83HN0GTJ6D |
| Cyclosporine | CYCLOSPORINE | Apotex Corp | 70c8a4a6-ebe2-457f-a626-400c338cec2d | 2024-09-23 | Warnings, Adverse reactions | 83HN0GTJ6D |
| Cyclosporine | CYCLOSPORINE | KVK-TECH, INC. | a7040dc6-063b-40ee-8f2a-153e87b08430 | 2024-09-23 | Warnings, Adverse reactions | 83HN0GTJ6D |
| RESTASIS | CYCLOSPORINE | Allergan, Inc. | 8e24af2b-bc1c-4849-94f2-6df950cdca89 | 2024-09-09 | Warnings, Adverse reactions | 83HN0GTJ6D |
| CYCLOSPORINE | CYCLOSPORINE | Lupin Pharmaceuticals, Inc. | 9aca2026-af86-4e97-925e-c202b87c46ac | 2024-09-01 | Warnings, Adverse reactions | 83HN0GTJ6D |
| Gengraf | CYCLOSPORINE | AbbVie Inc. | e896cbfe-4745-4088-82a3-8dc10b75c41f | 2024-08-21 | Boxed warning, Warnings, Adverse reactions | 83HN0GTJ6D |
| Cyclosporine | CYCLOSPORINE | Teva Pharmaceuticals USA, Inc. | f3dc2a50-1084-4190-a6f3-37034a04db86 | 2024-07-01 | Boxed warning, Warnings, Adverse reactions | 83HN0GTJ6D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.